Invention Grant
- Patent Title: Urogenital medical device formulation based on suitable biochemical compositions for the stabilization of the acidity and the redox state of the vaginal fluid
-
Application No.: US16465208Application Date: 2017-11-30
-
Publication No.: US11235060B2Publication Date: 2022-02-01
- Inventor: Federico Graf
- Applicant: PROBIOSWISS AG
- Applicant Address: CH Beckenried
- Assignee: PROBIOSWISS AG
- Current Assignee: PROBIOSWISS AG
- Current Assignee Address: CH Beckenried
- Agency: Cantor Colburn LLP
- Agent Bryan D. Zerhusen; Nicholas R. Herrel
- Priority: WOPCT/IB2016/057218 20161130
- International Application: PCT/IB2017/057547 WO 20171130
- International Announcement: WO2018/100533 WO 20180607
- Main IPC: A61K47/12
- IPC: A61K47/12 ; A61P31/04 ; A61K9/00 ; A61P31/10 ; A61K9/06 ; A61K9/48 ; A61K31/19 ; A61K35/747 ; A61K45/06 ; A61K47/18 ; A61K47/20 ; A61K47/26 ; A61K47/32 ; A61K47/36 ; A61K35/00
Abstract:
The invention relates to compositions for vaginal or, alternatively, oral administration and to the use of such compositions for stabilizing the vaginal, or, alternatively, the intestinal acidity and establishing favorable conditions for the inhibition of pathogens and the growth of lactobacilli in the urogenital, or, alternatively, gastro-intestinal tract.
Public/Granted literature
Information query
